Dudediligence.

Vir Biotechnology, Inc

VIRNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

169.2M

on 2026-06-30, from 135.8M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

50M100M150MMar2024JunSepDecMar2025JunSepDecMar2026$8.50Jun

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

1 of its filings are not read yet.

Warrants

The 10-Q filed 2026-08-05 is not read yet.

Cash

10.4 quarters

$528.6M on 2026-06-30 ÷ $50.6M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-02-25Public offering17,647,059$8.50$150.0M424B5 ↗